As JPMorgan Chase's CEO, Jamie Dimon, highlights Europe's dwindling competitiveness, investors are urged to look beyond seemingly attractive valuations. Persistent disadvantages in energy costs, regulatory burden, and fragmented capital markets...
Render ($RENDER) has defied correction forecasts, buoyed by its pivotal role in the AI infrastructure narrative, surpassing mere technical indicators. The network's emphasis on addressing the global GPU compute shortage...
The US Department of Defense's pivot towards unmanned aerial systems is sparking an investment surge across both established contractors and nimble startups. As companies vie for lucrative production contracts, the...
In today's investment climate, unverified bullish claims on social media often distort stock prices, leading to fragile trades detached from fundamentals. Disciplined investors must transcend superficial narratives, focusing on a...
Balancing a portfolio often feels like walking a tightrope; too few stocks increase idiosyncratic risk, while too many lead to the dreaded 'di-worsification'. The sweet spot, though historically around 20-30...
Jeff Bezos is parting with up to 50 million Amazon shares in a meticulously planned divestment strategy, set to culminate by January 2025. This is less a harbinger of doom...
US Representative Mike McCaul has made notable moves in the semiconductor sector, offloading Nvidia shares and investing in ASML. This strategic shift from AI momentum to foundational tech infrastructure reflects...
Jeff Bezos's strategic divestment of Amazon shares totalling $8.5 billion is part of a systematic plan begun in late 2023. This initiative reflects strategic capital reallocation and personal financial planning,...
The Nasdaq Composite's latest record high hides a complex and concentrated reality, driven primarily by a few mega-cap tech titans like Nvidia and Microsoft. While soaring valuations echo the heady...
IGC Pharma has unveiled MINT-AD, an innovative AI platform that aims to predict Alzheimer's risk long before symptoms appear by analysing diverse data sets such as genetic markers and lifestyle...
